BRISTOL MYERS SQUIBB CO

BRISTOL MYERS SQUIBB CO (BMY) is currently classified as Pharmaceuticals within Pharmaceuticals (Healthcare). Classification confidence: 0.92 (verified market data). Capital structure on the latest snapshot: total assets 86,476,000,000 USD, total equity 20,068,000,000, short-term debt 1,988,000,000, long-term debt 42,152,000,000. Net cash position is approximately -34,566,000,000 USD. Profitability profile: revenue 11,489,000,000, gross profit 0, operating income 0, net income 2,677,000,000. Return on equity ~13.3%. Return on assets ~3.1%. Operating-cash-flow to net-income ratio is 0.41. Risk profile from automated assessment: liquidity risk medium, dilution risk medium. Flags: Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk.. Management commentary signal: or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement..